| Financial Year |
March 31 2023 |
| Monetary Funds |
781,658,668.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
787,716.88 |
| Accounts Receivable |
165,515,052.40 |
| Advances to Suppliers |
16,342,329.01 |
| Other Receivables |
8,348,942.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,174,810.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,512,807.22 |
| Total Current Assets |
1,070,502,237.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
146,691,081.59 |
| Fixed Assetes |
435,873,827.02 |
| Under-construction Projects |
6,410,742.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,655,144.28 |
| R&D expenses |
-- |
| Goodwill |
159,543,655.27 |
| Long-Term Deferred and Prepaid Expenses |
22,820,408.26 |
| Deferred Income Tax Assets |
32,719,582.67 |
| Other Non-Current Assets |
3,678,413.94 |
| Sub-Total of Non-Current Assets |
870,736,923.10 |
| Total Assets |
1,941,239,161.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
17,188,497.94 |
| Accounts Received In Advance |
756,668.60 |
| Employee Compensation Payable |
832,176.14 |
| Taxes Payable |
10,593,023.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,583,080.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,049,541.48 |
| Other Current Liabilities |
623,663.60 |
| Sub-Total of Current Liabilities |
90,237,465.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
33,193,760.11 |
| Deferred Income Tax Liabilities |
4,339,574.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,424,921.10 |
| Total Liabilities |
150,662,386.21 |
| Paid-In Capital(Or Share Stock) |
544,011,487.00 |
| Capital Surplus |
610,812,561.86 |
| Surplus Reserve |
70,302,733.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
510,474,221.53 |
| Minority Stockholder's Interest |
54,975,770.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,735,601,004.17 |
| Owner's Equity（Stockholder's Equity） |
1,790,576,774.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,941,239,161.02 |
